These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2248082)

  • 1. Potentiation of the pressor effect of intravenously administered tyramine during moclobemide treatment.
    Zimmer R; Fischbach R; Breuel HP
    Acta Psychiatr Scand Suppl; 1990; 360():76-7. PubMed ID: 2248082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between orally administered tyramine and moclobemide.
    Zimmer R; Puech AJ; Philipp F; Korn A
    Acta Psychiatr Scand Suppl; 1990; 360():78-80. PubMed ID: 2248083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors.
    Zimmer R
    Acta Psychiatr Scand Suppl; 1990; 360():81-3. PubMed ID: 2248084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyramine pressor effect in man: studies with moclobemide, a novel, reversible monoamine oxidase inhibitor.
    Korn A; Da Prada M; Raffesberg W; Allen S; Gasic S
    J Neural Transm Suppl; 1988; 26():57-71. PubMed ID: 3162952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyramine pressor response with moclobemide--a reversible monoamine oxidase inhibitor.
    Tiller JW; Maguire KP; Davies BM
    Psychiatry Res; 1987 Nov; 22(3):213-20. PubMed ID: 3432450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between moclobemide and oral tyramine in depressed patients.
    Burgess CD; Mellsop GW
    Fundam Clin Pharmacol; 1989; 3(1):47-52. PubMed ID: 2714732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of moclobemide, a new reversible monoamine oxidase inhibitor, on absorption and pressor effect of tyramine.
    Korn A; Da Prada M; Raffesberg W; Gasic S; Eichler HG
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):17-23. PubMed ID: 2450251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination and comparison of the pressor effect of tyramine during long-term moclobemide and tranylcypromine treatment in healthy volunteers.
    Berlin I; Zimmer R; Cournot A; Payan C; Pedarriosse AM; Puech AJ
    Clin Pharmacol Ther; 1989 Sep; 46(3):344-51. PubMed ID: 2673623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moclobemide, a new reversible MAO inhibitor--interaction with tyramine and tricyclic antidepressants in healthy volunteers and depressive patients.
    Korn A; Eichler HG; Fischbach R; Gasic S
    Psychopharmacology (Berl); 1986; 88(2):153-7. PubMed ID: 3081926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of moclobemide, a new reversible monoamine oxidase inhibitor with oral tyramine.
    Gieschke R; Schmid-Burgk W; Amrein R
    J Neural Transm Suppl; 1988; 26():97-104. PubMed ID: 3283292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure response to tyramine-enriched meal before and during MAO-inhibition in man: influence of dosage regimen.
    Müller T; Gieschke R; Ziegler WH
    J Neural Transm Suppl; 1988; 26():105-14. PubMed ID: 3162949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral linezolid on the pressor response to intravenous tyramine.
    Cantarini MV; Painter CJ; Gilmore EM; Bolger C; Watkins CL; Hughes AM
    Br J Clin Pharmacol; 2004 Nov; 58(5):470-5. PubMed ID: 15521893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyramine pharmacodynamics during combined administration of lazabemide and moclobemide.
    Dingemanse J; Hussain Y; Korn A
    Int J Clin Pharmacol Ther; 1996 Apr; 34(4):172-7. PubMed ID: 8861736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotensive action and weak potentiation of tyramine effect by moclobemide in rats.
    Da Prada M; Burkard WP
    Acta Psychiatr Scand Suppl; 1990; 360():106-7. PubMed ID: 2248060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of food on the tyramine pressor effect during chronic moclobemide treatment of healthy volunteers.
    Audebert C; Blin O; Monjanel-Mouterde S; Auquier P; Pedarriosse AM; Dingemanse J; Durand A; Cano JP
    Eur J Clin Pharmacol; 1992; 43(5):507-12. PubMed ID: 1483487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the pressor effect of tyramine after treatment with phenelzine and moclobemide in healthy male volunteers.
    Simpson GM; Gratz SS
    Clin Pharmacol Ther; 1992 Sep; 52(3):286-91. PubMed ID: 1526086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a novel monoamine-oxidase inhibitor, moclobemide on the sensitivity to intravenous tyramine and norepinephrine in humans.
    Cusson JR; Goldenberg E; Larochelle P
    J Clin Pharmacol; 1991 May; 31(5):462-7. PubMed ID: 2050833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline.
    Korn A; Wagner B; Moritz E; Dingemanse J
    Eur J Clin Pharmacol; 1996; 49(4):273-8. PubMed ID: 8857072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacology of moclobemide during chronic administration of high doses to healthy subjects.
    Dingemanse J; Wood N; Guentert T; Oie S; Ouwerkerk M; Amrein R
    Psychopharmacology (Berl); 1998 Nov; 140(2):164-72. PubMed ID: 9860107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyramine potentiation during treatment with MAO inhibitors: brofaromine and moclobemide vs irreversible inhibitors.
    Bieck PR; Antonin KH
    J Neural Transm Suppl; 1989; 28():21-31. PubMed ID: 2794993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.